Trade this ETF at your broker
Index | Morningstar US Small Cap Target Market Exposure |
Investment focus | Equity, United States, Small Cap |
Fund size | EUR 120 m |
Total expense ratio | 0.14% p.a. |
Replication | Physical (Full replication) |
Legal structure | ETF |
Strategy risk | Long-only |
Sustainability | No |
Fund currency | USD |
Currency risk | Currency unhedged |
Volatility 1 year (in EUR) | 18.28% |
Inception/ Listing Date | 9 August 2022 |
Distribution policy | Distributing |
Distribution frequency | Quarterly |
Fund domicile | Ireland |
Fund Provider | J.P. Morgan |
Fund Structure | Open-ended Investment Company (OEIC) |
UCITS compliance | Yes |
Administrator | Brown Brothers Harriman Fund Administration Services (Ireland) Limited |
Investment Advisor | J. P. Morgan Investment Management Inc. |
Custodian Bank | Brown Brothers Harriman Trustee Services (Ireland) Limited |
Revision Company | PricewaterhouseCoopers (Ireland) |
Fiscal Year End | 31 December |
Swiss representative | JPMorgan Asset Management (Switzerland) LLC |
Swiss paying agent | J.P. Morgan (Suisse) SA |
Tax data | Bundesanzeiger | |
Germany | Unknown | |
Switzerland | ESTV Reporting | |
Austria | Tax Reporting Fund | |
UK | UK Reporting |
Indextype | - |
Swap counterparty | - |
Collateral manager | |
Securities lending | No |
Securities lending counterparty |
MicroStrategy | 0.43% |
Pure Storage | 0.40% |
Carlisle Cos | 0.39% |
DraftKings Inc | 0.37% |
AppLovin | 0.35% |
EMCOR Group | 0.35% |
Williams-Sonoma | 0.35% |
Reliance Inc | 0.33% |
Manhattan Associates | 0.31% |
Sarepta Therapeutics | 0.29% |
United States | 92.53% |
Bermuda | 1.07% |
Other | 6.40% |
Industrials | 18.05% |
Consumer Discretionary | 14.48% |
Financials | 14.47% |
Technology | 14.22% |
Other | 38.78% |
Broker | Rating | Order fee | ETF savings plans | |
---|---|---|---|---|
0.99€ | 2536 | View offer* | ||
0.00€ | 898 | View offer* | ||
0.00€ | 785 | View offer* | ||
5.90€ | 1571 | View offer* | ||
6.15€ | 1085 | View offer* |
YTD | +4.47% |
1 month | -3.25% |
3 months | -2.24% |
6 months | +3.39% |
1 year | +10.77% |
3 years | - |
5 years | - |
Since inception (MAX) | +7.31% |
2023 | +14.32% |
2022 | - |
2021 | - |
2020 | - |
Current dividend yield | 0.96% |
Dividends (last 12 months) | EUR 0.24 |
Period | Dividend in EUR | Dividend yield in % |
---|---|---|
1 Year | EUR 0.24 | 1.05% |
2023 | EUR 0.28 | 1.32% |
Volatility 1 year | 18.28% |
Volatility 3 years | - |
Volatility 5 years | - |
Return per risk 1 year | 0.59 |
Return per risk 3 years | - |
Return per risk 5 years | - |
Maximum drawdown 1 year | -11.75% |
Maximum drawdown 3 years | - |
Maximum drawdown 5 years | - |
Maximum drawdown since inception | -19.31% |
Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
---|---|---|---|---|---|
London Stock Exchange | GBX | BBDS | BBDS LN BBSDGBIV | BBDS.L BBSDGBiv.P | |
London Stock Exchange | USD | BBSD | BBSD LN BBSDUSIV | BBSD.L BBSDUSiv.P |
Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
---|---|---|---|---|
JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (acc) | 33 | 0.14% p.a. | Accumulating | Full replication |